Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Elite has four ANDAs, ALL filed and under FDA review:
1. Methotrexate ANDA used to treat inflammatory arthritis.
2. Dopamine agonist ANDA for the treatment of Parkinson's.
3. OxyContin ANDA for treatment of pain management .
4. Vyvance ANDA used for attention deficit disorder.
ELTP
State Capital Gains Tax Rates
1 California 13.30% 13.30%
2 New Jersey * 10.75% 10.75%
2 Washington D.C. 10.75% 10.75%
4 Oregon * 9.90% 9.90%
5 Minnesota 9.85% 9.85%
6 Massachusetts 9.00% 5.00%
7 New York * 10.90% 10.90%
8 Vermont 8.75% 8.75%
9 Wisconsin * 7.65% 7.65%
10 Hawaii * 7.25% 7.25%
11 Maine 7.15% 7.15%
12 Washington † 7.00% 7.00%
13 Connecticut 6.99% 6.99%
14 Montana * 6.75% 6.75%
15 Nebraska 6.64% 6.84%
16 Delaware * 6.60% 6.60%
17 West Virginia 6.50% 6.50%
18 South Carolina * 6.40% 6.50%
19 Iowa * 6.00% 8.53%
20 Rhode Island 5.99% 5.99%
21 New Mexico * 5.90% 5.90%
22 Idaho 5.80% 6.00%
23 Georgia 5.75% 5.75%
23 Maryland * 5.75% 5.75%
23 Virginia 5.75% 5.75%
26 Kansas 5.70% 5.70%
27 Alabama * 5.00% 5.00%
27 Mississippi 5.00% 5.00%
29 North Carolina 4.75% 4.99%
30 Illinois 4.95% 4.95%
31 Arkansas * 4.90% 4.90%
32 Utah 4.85% 4.85%
33 Oklahoma 4.75% 4.75%
34 Kentucky * 4.50% 5.00%
34 Missouri * 4.95% 5.30%
36 Colorado 4.40% 4.40%
37 Louisiana 4.25% 4.25%
37 Michigan * 4.25% 4.25%
39 Ohio * 3.99% 3.99%
40 Indiana * 3.15% 3.23%
41 Pennsylvania * 3.07% 3.07%
42 North Dakota * 2.90% 2.90%
43 Arizona 2.50% 2.98%
44 Alaska 0.00% 0.00%
45 Florida 0.00% 0.00%
46 Nevada 0.00% 0.00%
47 New Hampshire 0.00% 0.00%
48 South Dakota 0.00% 0.00%
49 Tennessee 0.00% 0.00%
50 Texas 0.00% 0.00%
51 Wyoming 0.00% 0.00%
My funds did not come today.
Im not trading so it doesnt matter to much where it closes.
I have funds coming so less gets me more shares.
Im still in the accumulate as many shares as I can in the next 22 months phase for THE Buy Out.
The excitement is going to go through the roof between now and July 01
Thoughts
Locked $$ Loaded ELTP
Why ?
Im thinking down the road about the buy out in 22 months
$2
$3
$4 How much will we go for ?
GLTY
Enjoy the Ride !!!!
The Wall !!!!!!!!!
Im gonna be Richer !!!!!!!!!!!!!!!
What about the trials that were found in India ??
I think they are referring to generic market share only which does not include Branded product $$ ??
One other site said it was a $600 million market but probably includes injectable product
We have different Mothers
At next CC are we asking Nasrat if he is going to Vegas with us all ?
Or will the Buy Out aftermath have him tied up for awhile ?
Catalyst check off:
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
X 13. Vigabatrin Approval $233 Million
__14. Pyros Settle Vigabatrin -VigPoder trade mark challenge then Launch
__15. Generic Methotrexate Approval- Antimetabolite $42 Million
__16. $50 million in yearly revenues
X 17. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
__18. Generate revenues over $20 million/quarter
__19. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__20. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
__21. European distribution - Dexcel partnership approval by Israeli Health
__22. Full ownership of Adderall IR $ 335 Million
__23. Full ownership of Adderall XR $ 1.56 Billion
__24. Generic Concerta- $1.2 BILLION FDA submission
__25. $100 million in yearly revenue
__26. Generic Vyvanse Approval and Launch
__27. $200 million in yearly revenue
__28. Deep pocket partner for SequestOx
__29. Patented Unique ADF (w/o naltrexone)-- NDA
__30. Mikah ANDA (s)
__31. Undisclosed ANDAs/NDAs
__32. DollarLand PPS
__33. Uplist to the NASDAQ Exchange
__34. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__35. Vegas Baby !!!!!!!
X 36. PE below 8
Sorry @ JJ
I’ve never had a pile driver.
May try it.
Has to be cold out side ?
Shortages:
FDA shortage link
for Adderall:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c
FDA shortage link for Methotrexate
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methotrexate%20Sodium%20Tablet&st=c
Thanks, My freinds say the same thing. In a Good way though.
Its a way of life.
HammerBottom is the best place to buy accumulate shares. Best time now since hammer has pasted is before the buyout.
A few cents one way or another wont matter much at Buy Out prices.
Savvy
Enjoy the ride to Buy Out !
GL
Looks like the kids down the road from me.
Things have gone full circle
Catalyst check off:
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
__13. Generic Methotrexate - Antimetabolite $42 Million
__14. $50 million in yearly revenues
X 15. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
__16. Generate revenues over $20 million/quarter
__17. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__18. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
__19. European distribution - Dexcel partnership approval by Israeli Health
__20. Full ownership of Adderall IR $ 335 Million
__21. Full ownership of Adderall XR $ 1.56 Billion
__22. Generic Concerta- $1.2 BILLION FDA submission
__23. Vigabatrin - APPROVED - VigPoder Pyros $233 Million trade mark challenge
__24. $100 million in yearly revenue
__25. Generic Vyvanse Approval and Launch
__26. $200 million in yearly revenue
__27. Deep pocket partner for SequestOx
__28. Patented Unique ADF (w/o naltrexone)-- NDA
__29. Mikah ANDA (s)
__30. Undisclosed ANDAs/NDAs
__31. DollarLand PPS
__32. Uplist to the NASDAQ Exchange
__33. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__34.. Vegas Baby !!!!!!!
X 35. PE below 8
People finding is late will get 10-20X over 22 months.
Do the DD
Most 600% gains over a few weeks have a pull back before it resumes to higher highs . Traders sold at 21 and are now buying back more than what they had initially. Welcome to the OTC>
Congrats finding The Jewel of the OTC ELTP
IF anyone finds a better otc stock please share.
No body has found any better since Ive been here.
NO one has come upwith a better otc stock since the HammerBottom
Life changing $$ is filling our accounts.
GLTY
Buyout in 22 months approximatly
Thoughts
I bought a few thousnad around 31 when Nasrat bought some for his IRA.
I waited for the HammerBottom and bought Millions between 2 cents and 4.5 cents..
been green since a nickel land.
Other family members are doing even better because they ran out of $ at a nickel
Still adding 100,000 a week avg. some higher than where we are today.
thanks for the help getting them at the dips along the way.
Buy Out will be a new holiday to celebrate every year.
Life Changing wealth is accumulating in our accounts.
GLTA share holders
Don't look into the Sun
Dont wait too long DollarLand is in sight 22 months
The First Millioaire maker run to $0.97 IN 2014
Thats why I have so many FREE shares SICE THE 2 CENT hAMMERBOTTOM
bUYoUT WILL END THIS IN dOLLARlAND
tHOUGTS?
im Shooting for Wednesday $$$$$$$$$$$$$$$$$$$$$$$
It was mostly Roths but other accounts have more now.
I do Roth for myself and family members every year but thats not enough shares for me, LOL
I would rather Elite stay in the Shortage lists, LOL
I might add, with Ours being in the Available column
Updated:
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
__13. Generic Methotrexate - Antimetabolite $42 Million
__14. $50 million in yearly revenues
X 15. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
__16. Generate revenues over $20 million/quarter
__17. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__18. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
__19. European distribution - Dexcel partnership approval by Israeli Health
__20. Full ownership of Adderall IR $ 335 Million
__21. Full ownership of Adderall XR $ 1.56 Billion
__22. Generic Concerta- $1.2 BILLION FDA submission
__23. Vigabatrin - APPROVED - VigPoder Pyros $233 Million trade mark challenge
__24. $100 million in yearly revenue
__25. Generic Vyvanse Approval and Launch
__26. $200 million in yearly revenue
__27. Deep pocket partner for SequestOx
__28. Patented Unique ADF (w/o naltrexone)-- NDA
__29. Mikah ANDA (s)
__30. Undisclosed ANDAs/NDAs
__31. DollarLand PPS
__32. Uplist to the NASDAQ Exchange
__33. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__34.. Vegas Baby !!!!!!!
X 35. PE below 8
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
__13. Undisclosed Antimetabolite ANDA- $42 Million
__14. $50 million in yearly revenues
X 15. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
__16. Generate revenues over $20 million/quarter
__17. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__18. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
__19. European distribution - Dexcel partnership approval by Israeli Health
__20. Full ownership of Adderall IR $ 335 Million
__21. Full ownership of Adderall XR $ 1.56 Billion
__22. Generic Concerta- $1.2 BILLION FDA submission
__23. Vigabatrin - APPROVED - VigPoder Pyros $233 Million trade mark challenge
__24. $100 million in yearly revenue
__25. Generic Vyvanse Approval and Launch
__26. $200 million in yearly revenue
__27. Partner for SequestOx
__28. Patented Unique ADF (w/o naltrexone)-- NDA
__29. Mikah ANDA (s)
__30.Undisclosed ANDAs/NDAs
__31. Antimetabolite ANDA- Methotrexate -$600 Million - unconfirmed
__32. DollarLand PPS
__33. Uplist to the NASDAQ Exchange
__34. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__35. Vegas Baby !!!!!!!
X 36. PE below 8
Another million shares?
I’m adding mid week.
I have till July to load another boat load.
Is a CRL material ?
I’m putting up a For Sale sign up tomorrow .
Don’t know how long it will take.
Hopefully before next CC and financials
ELTP
Let’s do the math :
We are gonna need a bigger calculator !
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
__13. Undisclosed Antimetabolite ANDA- $42 Million
__14. $50 million in yearly revenues
__15. Generate revenues over $20 million/quarter
__16. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__17. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
X 18. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
__19. European distribution - Dexcel partnership approval by Israeli Health
__20. Full ownership of Adderall IR $ 335 Million
__21. Full ownership of Adderall XR $ 1.56 Billion
__22. Generic Concerta- $1.2 BILLION FDA submission
__23. Vigabatrin - APPROVED - VigPoder Pyros $233 Million trade mark challenge
__24. $100 million in yearly revenue
__25. Generic Vyvanse Approval and Launch
__26. $200 million in yearly revenue
__27. Patented Unique ADF (w/o naltrexone)-- NDA
__28. Mikah ANDA (s)
__29. Undisclosed ANDAs/NDAs
__30. Antimetabolite ANDA- Methotrexate -$600 Million - unconfirmed
__31. DollarLand PPS
__32. Uplist to the NASDAQ Exchange
__33. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__34. Vegas Baby !!!!!!!
I think his implying a $250 million / year rev worst case scenario as the Vyvance market shrinks as Elite/Kirkov takes the market from branded.
5% of Elite’s combined $10 Billion IMS markets is $500 million. Unless they can take more of the market.
They are currently getting 10% of Adderall market.
This is about to Get Real !!!!
How much would someone pay for 5% of $10 Billion/ yr in revenues ?
Your leaving off the fact that we rebought at the HammerBottom. Kagillians of free shares
The biggest catalyst is BuyOut in 22 months. Time to get tax situations maxed out. Move to FL etc.
Long term capital gains if invested now. Where else can you have a 13 cent stock go to $2.00 + in less than 2 years ?
Patience is a virtue
LOCKED $$ LOADED